Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain

Biochemical and Biophysical Research Communications

Volumn 357, Issue 4, 2007, Pages 971-976

  Lee, Boyoung ^a   Kim, Jaehyung ^a   Kim, Sung Jin ^b   Lee, Heuiran ^b   Chang, Jin Woo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Dorsal root ganglion; GABA; Glutamate decarboxylase 65; Neuropathic pain; Recombinant adeno associated virus

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE 65 ANTIBODY;

ADENO ASSOCIATED VIRUS; ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE MODEL; DRUG RELEASE; FEMALE; HUMAN; HUMAN CELL; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SPINAL GANGLION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; GAMMA-AMINOBUTYRIC ACID; GENE THERAPY; GLUTAMATE DECARBOXYLASE; ISOENZYMES; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSFECTION; TREATMENT OUTCOME;

ADENO-ASSOCIATED VIRUS; RATTUS;

EID: 34247889863     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.061     Document Type: Article

References (32)

1. Bridges D., Thompson S.W., and Rice A.S. Mechanisms of neuropathic pain. Br. J. Anaesth. 87 (2001) 12-26
2. Decosterd I., and Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87 (2000) 149-158
3. Moore K.A., Kohno T., Karchewski L.A., Scholz J., Baba H., and Woolf C.J. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J. Neurosci. 22 (2002) 6724-6731
4. Moore K., Kohno T., Scholz J., Karchewski L.A., and Woolf C.J. Spinal disinhibition:a role in neuropathic pain?. Neurosci. News 4 (2001) 5-10
5. Wilson S.P., Yeomans D.C., Bender M.A., Lu Y., Goins W.F., and Glorioso J.C. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc. Natl. Acad. Sci. USA 96 (1999) 3211-3216
6. Liu J., Wolfe D., Hao S., Huang S., Glorioso J.C., Mata M., and Fink D.J. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol. Ther. 10 (2004) 57-66
7. Hao S., Mata M., Wolfe D., Glorioso J.C., and Fink D.J. Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann. Neurol. 57 (2005) 914-918
8. Wang L., Muramatsu S., Lu Y., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Hanazono Y., Kume A., Urano F., Ichinose H., Nagatsu T., Nakano I., and Ozawa K. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther. 9 (2002) 381-389
9. Burger C., Gorbatyuk O.S., Velardo M.J., Peden C.S., Williams P., Zolotukhin S., Reier P.J., Mandel R.J., and Muzyczka N. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10 (2004) 302-317
10. Fleming J., Ginn S.L., Weinberger R.P., Trahair T.N., Smythe J.A., and Alexander I.E. Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons. Hum. Gene Ther. 12 (2001) 77-86
11. Burger C., Nash K., and Mandel R.J. Recombinant adeno-associated viral vectors in the nervous system. Hum. Gene Ther. 16 (2005) 781-791
12. Lee B., Lee H., Nam Y.R., Oh J.H., Cho Y.H., and Chang J.W. Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models. Gene Ther. 12 (2005) 1215-1222
13. Xu Y., Gu Y., Wu P., Li G.W., and Huang L.Y. Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors. Hum. Gene Ther. 14 (2003) 897-906
14. A.J. Todd, D.J. Maxwell, GABA in the mammalian spinal cord, in: D.L. Martin, R.W. Olsen (Eds.), GABA in the Nervous Systems: The View at Fifty Years, 2000.
15. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., and Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 7 (1991) 91-100
16. Soghomonian J.J., and Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol. Sci. 19 (1998) 500-505
17. Martin D.L., and Tobin A.J. Mechanisms controlling GABA synthesis and degradation in the brain. GABA in the Nervous System: The View at Fifty Years (2000), Williams & Wilkins, Philadelphia, PA, USA
18. Mi J., Chatterjee S., Wong K.K., Forbes C., Lawless G., and Tobin A.J. Recombinant adeno-associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines. J. Neurosci. Res. 57 (1999) 137-148
19. Mackie M., Hughes D.I., Maxwell D.J., Tillakaratne N.J., and Todd A.J. Distribution and colocalisation of glutamate decarboxylase isoforms in the rat spinal cord. Neuroscience 119 (2003) 461-472
20. Nam Y.R., Kim S.J., Lee B., Chang J.W., Joo C.H., Kim Y.K., and Lee H. Analysis of the production efficiency and titration of various recombinant adeno-associated viruses. Oncol. Rep. 12 (2004) 761-766
21. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
22. Lee B.H., Won R., Baik E.J., Lee S.H., and Moon C.H. An animal model of neuropathic pain employing injury to the sciatic nerve branches. Neuroreport 11 (2000) 657-661
23. Ahn J., Joo C.H., Seo I., Kim D., Kim Y.K., and Lee H. All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J. Med. Virol. 75 (2005) 290-294
24. Dowdall T., Robinson I., and Meert T.F. Comparison of five different rat models of peripheral nerve injury. Pharmacol. Biochem. Behav. 80 (2005) 93-108
25. Catheline G., Le Guen S., and Besson J.M. Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: a Fos study. Pain 92 (2001) 389-398
26. Kaplitt M.G., Leone P., Samulski R.J., Xiao X., Pfaff D.W., O'Malley K.L., and During M.J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8 (1994) 148-154
27. Kim D.K., and Byun J. The pJDK vector contains the human cytomegalovirus enhancer/promoter-driven expression cassette within the inverted terminal repeats of AAV-2. Patent Pending in Korea (2002) 10-2002-0008232
28. Byun J., Heard J.M., Huh J.E., Park S.J., Jung E.A., Jeong J.O., Gwon H.C., and Kim D.K. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector. J. Mol. Cell Cardiol. 33 (2001) 295-305
29. Gu Y., Xu Y., Li G.W., and Huang L.Y. Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine. J. Pain 6 (2005) 447-454
30. Xu J., Ma C., Bass C., and Terwilliger E.F. A combination of mutations enhances the neurotropism of AAV-2. Virology 341 (2005) 203-214
31. Eaton M.J., Plunkett J.A., Karmally S., Martinez M.A., and Montanez K. Changes in GAD- and GABA- immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic precursors. J. Chem. Neuroanat. 16 (1998) 57-72
32. Castro-Lopes J.M., Tavares I., and Coimbra A. GABA decreases in the spinal cord dorsal horn after peripheral neurectomy. Brain Res. 620 (1993) 287-291